AXIM BIOTECHNOLOGIES, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 63.85B | - | |||||
| 41.83B | ||||||
| 40.47B | ||||||
| 27.17B | ||||||
| 26.52B |
